" class="no-js "lang="en-US"> Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference - Medtech Alert
Saturday, February 04, 2023

Breaking News

Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest enGene Appoints Alex Nichols, PhD as President and Chief Operating Officer Orexo Submits New Drug Application to FDA for OX124, a High-dose Rescue Medication for Opioid Overdose Abbott Announces US and European Approvals for New Technologies to Support Effective Treatment for Abnormal Heart Rhythms RefleXion Receives FDA Clearance for Biology-Guided Radiotherapy Treatment for Early and Late-stage Cancers Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer
Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference | Pharmtech Focus

April 8 2021

Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat during the Goldman Sachs Recovery Inoculated: The Current Outlook for COVID-19 Vaccines, Treatments, Testing and the Economy virtual conference. Novavax’ COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion.

Fireside chat details:
Date: Tuesday, April 13, 2021
Time: 2:30 – 3:20 p.m. Eastern Time (ET)
Panel title: COVID-19 Vaccines – Staying Ahead of the Curve
Novavax participant: Vivek Shinde, M.D., M.P.H., Vice President, Clinical Development
This event is open to Goldman Sachs clients.

Companies In This Post

Novavax | Pharmtech Focus

Novavax
  1. Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer

    Appointments

     Read more
  2. Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials

    Clinical Trials

     Read more
  3. Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe

    Industry News

     Read more
  4. Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch

    News

     Read more
  5. Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest

    Mergers & Aquisitions

     Read more
More On